IPO Alert: Glenmark Life Sciences Ltd.

Glenmark Life Sciences Limited (“GLS”) is a wholly-owned subsidiary of Glenmark Pharmaceuticals Ltd. The company is a leading developer and manufacturer of select high value, non-commoditized active pharmaceutical ingredients (“APIs”). GLS partners with 16 of the top 20 generic companies in the world and serves customers in multiple countries.

Bid/Offer Opens OnTuesday, 27-Jul-21
Bid/Offer Closes OnThursday, 29-Jul-21
Price BandRs. 695- Rs. 720 per equity share
Lot Size20 Shares


Finalization of Basis of Allotment3-Aug-21
Initiation of Refunds4-Aug-21
Credit of Shares to Demat Acct5-Aug-21
IPO Shares Listing Date6-Aug-21
UPI mandate expiry date12-Aug-21

How to Check Allotment Status

In case you have not been allotted or for any partial allotment of IPO shares, the blocked amount, if any, will be unblocked/released on or before UPI mandate expiry date as mentioned in the above table. Please reach out to your bank in case funds are not unblocked/released post the mandate expiry date.

Share button